Lipids
Lipids(脂质)
- Acyl-CoAs(13)
- Cyclooxygenase(543)
- Endocannabinoid/Endocannabinoid-like(145)
- Fatty Acid Conjugates(11)
- Fatty Acids(498)
- Fatty Alcohols/Aldehydes(16)
- Fatty Amides(77)
- Fatty Esters/Ethers(152)
- Glycerolipids(357)
- Glycerophospholipids(272)
- Hydrocarbons(15)
- Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids(146)
- Isoprostanes(36)
- Leukotrienes(69)
- Lipid Transport(11)
- Lipid-Based Drug Delivery(163)
- Lipoxins/Resolvin Es(10)
- Octadecanoids(124)
- Other Lipid Kinases(2)
- P450
- Polyketides(71)
- Prenol Lipids(19)
- Prostaglandins(483)
- Protein Lipidation(24)
- Reactive O2/N2 Pathways(116)
- Saccharolipids(2)
- Sphingolipids(359)
- Sterol Lipids(288)
- Thromboxanes(14)
- 11β-HSD
- 17β-HSD(2)
Lipids 相关产品(3019)
- GC40342cis-12-Octadecenoic Acid methyl esterCAS: 2733-86-0纯度: >96.00%
A monounsaturated fatty acid methyl ester
- GC40344cis-Vaccenic Acid methyl esterCAS: 1937-63-9纯度: >98.00%
A methyl ester form of cis-vaccenic acid
- GC40348trans-Vaccenic Acid methyl esterCAS: 6198-58-9纯度: >98.00%
An esterified from of trans-vaccnic acid
- GC403532,3-dinor Thromboxane B2CAS: 63250-09-9纯度: >98.00% / >95.00%
An abundant urinary metabolite of TXB 2
- GC40359(±)12-HEPECAS: 81187-21-5纯度: >98.00%
A non-enzymatic oxidation product of EPA that inhibits platelet aggregation
- GC40360(±)14(15)-EpETECAS: 131339-24-7纯度: >90.00%
An EPA congener of (±)14(15)-EpETrE with EDHF activity
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC40341 | Tetrahydro-11-deoxy Cortisol | 68-60-0 | >95.00% | |
A metabolite of 11-deoxycortisol | ||||
| GC40342 | cis-12-Octadecenoic Acid methyl ester | 2733-86-0 | >96.00% | |
A monounsaturated fatty acid methyl ester | ||||
| GC40343 | cis-9,10-Methyleneoctadecanoic Acid | 4675-61-0 | >98.00% | |
A cyclopropane fatty acid | ||||
| GC40344 | cis-Vaccenic Acid methyl ester | 1937-63-9 | >98.00% | |
A methyl ester form of cis-vaccenic acid | ||||
| GC40345 | Elaidic Acid methyl ester | 1937-62-8 | >98.00% | |
An esterified form of elaidic acid | ||||
| GC40347 | Phytomonic Acid | 503-06-0 | >98.00% | |
A saturated fatty acid | ||||
| GC40348 | trans-Vaccenic Acid methyl ester | 6198-58-9 | >98.00% | |
An esterified from of trans-vaccnic acid | ||||
| GC40349 | 12(S)-HETE-19,20-alkyne | - | >97.00% | |
A probe for 12(S)-HETE activity | ||||
| GC40350 | 15-deoxy-δ12,14-Prostaglandin A2 | 112839-31-3 | >98.00% | |
A synthetic analog of PGA 2 | ||||
| GC40353 | 2,3-dinor Thromboxane B2 | 63250-09-9 | >98.00% / >95.00% | |
An abundant urinary metabolite of TXB 2 | ||||
| GC40355 | (±)13-HpODE | 23017-93-8 | >95.00% | |
Hydroperoxide mixture derived from linoleic acid | ||||
| GC40356 | (±)9-HpODE | 5502-91-0 | >98.00% | |
A plant oxylipin | ||||
| GC40357 | 9(S)-HpODE | 29774-12-7 | >98.00% | |
A 5-LO product derived from linoleic acid | ||||
| GC40359 | (±)12-HEPE | 81187-21-5 | >98.00% | |
A non-enzymatic oxidation product of EPA that inhibits platelet aggregation | ||||
| GC40360 | (±)14(15)-EpETE | 131339-24-7 | >90.00% | |
An EPA congener of (±)14(15)-EpETrE with EDHF activity | ||||
| GC40361 | (±)15-HEPE | 88852-33-9 | >98.00% | |
A racemic mixture of EPA derivatives | ||||
| GC40362 | (±)18-HEPE | 141110-17-0 | >95.00% | |
Non-enzymatic oxidation product of EPA | ||||
| GC40363 | (±)5(6)-DiHETE lactone | - | >90.00% | |
A lactone form of (±)5(6)-DiHETE | ||||
| GC40364 | (±)5-HEPE | 83952-40-3 | >97.00% | |
Product of non-enzymatic oxidation of EPA | ||||
| GC40365 | (±)8(9)-EpETE | 851378-93-3 | >95.00% | |
Epoxygenase metabolite of EPA | ||||
| GC40366 | (±)8-HEPE | 99217-77-3 | >98.00% | |
A non-enzymatic oxidation product of EPA | ||||
| GC40367 | (±)9-HEPE | 286390-03-2 | >98.00% | |
A racemic mixture of EPA derivatives | ||||
| GC40368 | 11(R)-HEPE | 109430-11-7 | >98.00% | |
Produced by the oxidation of EPA by 11(R)-LO | ||||
| GC40369 | 11(S)-HEPE | 156473-26-6 | >98.00% | |
A monohydroxy fatty acid derived from EPA | ||||